Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenovirus Infection
BK Virus Infection
Cytomegaloviral Infection
Hematopoietic and Lymphoid Cell Neoplasm
JC Virus Infection
Malignant Solid Neoplasm
Symptomatic COVID-19 Infection Laboratory-Confirmed

Interventions

BIOLOGICAL: Virus-specific Cytotoxic T-lymphocytes

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]